Check the time stamp on this data. Updated AI-Generated Signals for Atara Biotherapeutics Inc. (ATRA) available here: ATRA.
Atara Biotherapeutics (NASDAQ:ATRA) has announced plans to cut around 50% of its workforce, just a little over a week after it said the FDA had declined to approve its immunotherapy Ebvallo.
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
At close: January 21 at 4:00:02 PM EST ...
China 30 Year Government Bond 0.0000 1.8592% ...
Polícia encontra cerca de 7 kg de maconha com jovem que pretendia vender a droga em São Francisco Segundo a Polícia Militar, a corporação recebeu uma denúncia anônima informando que um ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback